MacroLensNP नेपालीने Sign in Create accountSign up
Free · Life Insurance

SRLI Sanima Reliance Life Insurance Limited

Rs 378.10 +1.10 (+0.29%) as of 2026-11-06 15:00:00
Open
375.30
High
379.80
Low
375.30
Prev. close
377.00
Volume
6,405
Turnover
24.22 lakh
Avg volume (30 d)
34,183
52-week low Rs 348.00
high Rs 437.70 -13.6% from the 52-week high

Sanima Reliance Life Insurance Limited (SRLI) is listed on the Nepal Stock Exchange in the Life Insurance sector. Its share price is Rs 378.10 as of 6 November 2026, 13.6% below its 52-week high of Rs 437.70 and 8.6% above its 52-week low of Rs 348.00. It trades at a P/E of 49.4 on earnings per share of Rs 7.65, close to the Life Insurance sector's median P/E of 56.6.

SRLI paid a dividend in 3 of the last 3 fiscal years we track; the latest was 10.18% cash for FY 2081/2082. Promoters hold 51% of the shares and the public 49%.

Key figures latest report 2082/2083 Q4

Market value
1,896 crore · 18.96 arba
Shares listed
50,149,241
Paid-up capital
501.49 crore · 5.01 arba
EPS (annualised)
Rs 7.65
P/E
49.4
Book value / share
Rs 112.62
P/B
3.36
ROE
6.8%
ROA
1.19%
Dividend yield
2.69%
Net profit (annualised)
38.39 crore
Reserves
–
Total assets
3,227 crore · 32.27 arba
Debt to equity
4.71

Quarter by quarter trailing 12 months at each quarter

QuarterEPSEPS growth (y/y)Net profitRevenueROE
2082/2083 Q4 7.65 +1.7% 38.39 crore 624.42 crore · 6.24 arba 6.9%
2082/2083 Q3 7.59 -0.8% 38.07 crore 549.62 crore · 5.50 arba 6.9%
2082/2083 Q2 8.41 +16.3% 42.20 crore 589.50 crore · 5.90 arba 7.6%
2082/2083 Q1 7.86 +5.7% 39.42 crore 564.86 crore · 5.65 arba 7.0%
2081/2082 Q4 7.53 +7.6% 37.75 crore 544.05 crore · 5.44 arba 6.8%
2081/2082 Q3 7.65 +5.6% 38.36 crore 479.85 crore · 4.80 arba 6.9%
2081/2082 Q2 7.23 -17.4% 36.28 crore 511.42 crore · 5.11 arba 6.6%
2081/2082 Q1 7.44 -15.9% 37.29 crore 496.52 crore · 4.97 arba 6.9%

Dividends

Fiscal yearBonusCashBook close
2081/2082– 10.18% 26 Dec 2025
2080/20811.25% 8.00% 10 Mar 2025
2079/208018.38% – 27 Sep 2024

Bonus / right shares: Sep 2024 Bonus share 18.4%

Who owns it

Promoters 51% Public 49%
Public float
24,573,128 shares
Mutual funds hold
1.5% of the float
Promoter lock-in
–

MacroLens analysis of SRLI

More on SRLI on the full desk The rating and verdict, fair value, dump risk and warning signs, the 12-month target, the buy / sell meter with every past signal, cornering and broker activity - the analysis behind every number above. Create an account - 7-day trial

Other Life Insurance companies

CompanyPriceTodayP/EP/BMarket value
NLIC Nepal Life Insurance Co. Ltd. 740.00 +0.14% 150.75.87 7,015 crore · 70.15 arba
LICN Life Insurance Co. Nepal 799.00 +0.26% 108.34.49 4,395 crore · 43.95 arba
NLICL National Life Insurance Co. Lt... 580.00 -0.17% 89.14.54 3,301 crore · 33.01 arba
HLI Himalayan Life Insurance Limit... 303.00 -0.10% 87.13.25 2,770 crore · 27.70 arba
RNLI Reliable Nepal Life Insurance... 446.00 -0.67% 39.83.00 2,318 crore · 23.18 arba
PMLI Prabhu Mahalaxmi Life Insuranc... 429.00 +0.37% 60.63.68 2,277 crore · 22.77 arba
ALICL Asian Life Insurance Co. Limit... 422.20 -0.42% 53.53.51 2,217 crore · 22.17 arba
ILI IME Life Insurance Company Lim... 443.00 +0.07% 37.93.27 2,215 crore · 22.15 arba

Every Life Insurance company 14

Browse all NEPSE stocks by sector →

SRLI: common questions

What is the share price of SRLI today?

SRLI (Sanima Reliance Life Insurance Limited) closed at Rs 378.10 as of 6 November 2026 on NEPSE.

Does SRLI pay dividends?

SRLI paid a dividend in 3 of the last 3 fiscal years we track; the latest was 10.18% cash for FY 2081/2082.

What is the P/E ratio of SRLI?

It trades at a P/E of 49.4 on earnings per share of Rs 7.65, close to the Life Insurance sector's median P/E of 56.6.

Is SRLI a good buy?

This page is not buy or sell advice. MacroLens NP rates every NEPSE company on its fundamentals - SRLI's rating, fair value, dump risk and broker activity are on the desk, free for 7 days.

Prices from NEPSE; figures from the company's quarterly reports; dividends, ownership and news from public filings. Research, not a recommendation to buy or sell - see the risk disclosure.